Insider Trading Alert - CME, KEY And ALV Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, July 24, 2014, 36 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $109.40 to $3,127,697.40.

Highlighted Stocks Traded by Insiders:

CME Group (CME) - FREE Research Report

Piell Hilda Harris, who is Sr MD & Chief HR Officer at CME Group, sold 2,282 shares at $75.00 on July 24, 2014. Following this transaction, the Sr MD & Chief HR Officer owned 18,853 shares meaning that the stake was reduced by 10.8% with the 2,282-share transaction.

The shares most recently traded at $74.74, down $0.26, or 0.35% since the insider transaction. Historical insider transactions for CME Group go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares bought: 350
  • 12-Week # shares sold: 2,000
  • 24-Week # shares bought: 350
  • 24-Week # shares sold: 6,000

The average volume for CME Group has been 1.4 million shares per day over the past 30 days. CME Group has a market cap of $25.1 billion and is part of the financial sector and financial services industry. Shares are down 3.95% year-to-date as of the close of trading on Thursday.

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. The stock currently has a dividend yield of 2.51%. The company has a P/E ratio of 25.0. Currently, there are 7 analysts who rate CME Group a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CME - FREE

TheStreet Quant Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full CME Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

KeyCorp (KEY) - FREE Research Report

Parneros Demos, who is Director at KeyCorp, bought 4,000 shares at $13.63 on July 24, 2014. Following this transaction, the Director owned 4,000 shares meaning that the stake was boosted by 100% with the 4,000-share transaction.

The shares most recently traded at $13.83, up $0.20, or 1.45% since the insider transaction. Historical insider transactions for KeyCorp go as follows:

  • 4-Week # shares bought: 13,000
  • 12-Week # shares bought: 15,000
  • 24-Week # shares bought: 15,000

The average volume for KeyCorp has been 8.5 million shares per day over the past 30 days. KeyCorp has a market cap of $12.0 billion and is part of the financial sector and banking industry. Shares are up 2.46% year-to-date as of the close of trading on Thursday.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States. The stock currently has a dividend yield of 1.91%. The company has a P/E ratio of 13.9. Currently, there are 5 analysts who rate KeyCorp a buy, 1 analyst rates it a sell, and 14 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KEY - FREE

TheStreet Quant Ratings rates KeyCorp as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full KeyCorp Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Autoliv (ALV) - FREE Research Report

Chang Ket Leong, who is President Autoliv Asia at Autoliv, sold 2,000 shares at $102.56 on July 24, 2014. Following this transaction, the President Autoliv Asia owned 1,162 shares meaning that the stake was reduced by 63.25% with the 2,000-share transaction.

The shares most recently traded at $103.41, up $0.85, or 0.83% since the insider transaction. Historical insider transactions for Autoliv go as follows:

  • 4-Week # shares sold: 1,152
  • 12-Week # shares sold: 1,152
  • 24-Week # shares sold: 1,971

The average volume for Autoliv has been 443,800 shares per day over the past 30 days. Autoliv has a market cap of $9.5 billion and is part of the consumer goods sector and automotive industry. Shares are up 12.27% year-to-date as of the close of trading on Thursday.

Autoliv, Inc., through its subsidiaries, develops, manufactures, and supplies automotive safety systems to the automotive industry worldwide. The company operates in two segments, Passive Safety and Active Safety segments. The stock currently has a dividend yield of 2.1%. The company has a P/E ratio of 22.3. Currently, there is 1 analyst who rates Autoliv a buy, 3 analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALV - FREE

TheStreet Quant Ratings rates Autoliv as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Autoliv Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec